Dazodalibep
ishares biotechnology,horizon therapeutics,spdr s&p biotech
['dazodalibep', '$ibb', '$xbi']
new findings from phase 2 trial evaluating dazodalibep for sj gren's syndrome showcased at 2023 eular european congress of rheumatology 'ssyndrome more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt